Research Paper Volume 15, Issue 17 pp 8833—8850
Comprehensive analysis of ICD-related lncRNAs in predicting risk stratification, clinical prognosis and immune response for breast cancer
Figure 6. Immune infiltration assessment of ICDRLs risk subgroups. (A–D) Evaluation of immune status. (E) Evaluation of the proportions of 22 immune cells. (F) Analysis of the correlation between ICDRLs prognostic features, prognostic factors, and immune-infiltrating cells. (G–J) Analysis of the expression profiles of immune checkpoints in ICDRLs risk subgroups.